A shame the report was paid for but nevertheless a good summary of Regeneus' strengths/weaknesses. I think a valuation of $75-$90m in next 12 months is more realistic. Happy to be along for the ride, Progenza is a revolutionary product!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor